SIGN UP

Stay informed of the latest progress in canine health research.

DONATE

We need your support to fund research that helps dogs live longer, healthier lives.

 

Donate Today

Pilot study assesses feasibility of tissue collections and molecular profiling for personalized medicine studies

08/24/2011

By Kathy Stuebner, B.S., CVT, Research Coordinator, Clinical Investigation Center, College of Veterinary Medicine, and Michael S. Henson, D.V.M., Ph.D., Diplomate ACVIM (Oncology), Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Masonic Cancer Center

The University of Minnesota is a member of the Comparative Oncology Trials Consortium (COTC), a network of 20 academic comparative oncology centers that collaborate in multi-center trials managed by the Center for Cancer Research, which is part of the National Cancer Institute at the National Institutes of Health. While most COTC trials evaluate novel therapies for cancer, the main goal of this trial is to evaluate the capability of the COTC network of hospitals and laboratories around the country to collect and process samples quickly and accurately enough to be useful in personalized medicine trials in the future.

Oral
A dog with oral melanoma, a type of skin cancer. Scientists with the Animal Cancer Care and Research program are seeking dogs with oral melanoma for a study that will help both dogs and people with cancer.

Personalized medicine involves tailoring cancer treatment and prevention to the specific molecular nature of the individual and their cancer (i.e., target the mutations that drive malignant transformation, resistance to treatment, risk for toxicity, etc.). The hope is that targeted therapies will be more effective with less risk for the patient than traditional treatments.

For personalized medicine to be useful, we need to accurately determine the molecular characteristics (genomic, proteomic, and epigenetic profile) of the patient rapidly enough for treatments to be designed and implemented for patient care, ideally in less than a week. In addition to assessing sample collection, viability, and the clinical turnaround of results, we hope that this study will identify potential therapeutic targets in specific canine malignancies to allow the design of future studies in dogs. Since canine malignancies share many characteristics with those that occur in humans, if personalized medicine is proven efficacious in dogs, the results may advance development of more efficient targeted therapies for people, too.

University
Amber Winter of the College of Veterinary Medicine’s Clinical Investigation Center holds Luke, a study dog, as fourth-year veterinary student Raeana Rice examines the springer spaniel. Photo by Sue Kirchoff.

Once dogs are enrolled at the University of Minnesota Veterinary Medical Center, participation in the study involves a single collection of samples, specifically blood, saliva, and a biopsy of the tumor. After sample collection, owners can choose whatever treatment option is best for the family. The study pays for sample collection and provides $1,000 that can be used to cover the cost of evaluation and future expenses at the Veterinary Medical Center. At this time, we are specifically seeking golden retrievers with multicentric lymphoma, Scottish terriers with transitional cell carcinoma, and any breed of dog with oral melanoma.

This article is reprinted with permission from the University of Minnesota. It originally appears in the Summer 2011 Issue of Synergy the newsletter of the Animal Cancer Care and Research Program.

  • Printer Friendly

Listen to the Latest Podcast

CHF and Zoetis Reproduction Series: Cryopreservation of Canine Semen

03/27/2014

The AKC Canine Health Foundation (CHF) and our corporate alliance, Zoetis, are pleased to bring you the third installment in a podcast series devoted to canine reproduction education for pet owners, breeders, and veterinarians.

In this podcast Dr. Kit Kampschmidt of Brittmoore Animal Hospital in Houston Texas, discusses cryopreservation of canine semen. Dr. Kampschmidt received his DVM from Oklahoma State University in 1983. He has developed a special interest in canine reproduction and semen cryopreservation. He is a nationally recognized authority in these areas and serves as a consultant to other veterinarians through the Veterinary Information Network. He has been an invited speaker for national veterinary meetings, state and local veterinary associations, and many breed clubs. He has trained veterinarians from all over the United States and the world in canine semen freezing and artificial insemination techniques. He is a member of the Harris County Veterinary Medical Association, Texas Veterinary Medical Association, American Veterinary Medical Association, and American Animal Hospital Association, and currently serves on the board of directors for the Society for Theriogenology.

A transcript of this podcast is also available for those who prefer to read the interview.

Visit the Zoetis canine reproduction webpage for more information and resources.


Listen